The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line durvalumab with arterial chemotherapy in major portal invaded hepatocellular carcinoma: The phase 2 DurHope study with biomolecular analyses.
 
Ming Zhao
No Relationships to Disclose
 
Ning Lyu
No Relationships to Disclose
 
Junzhe Yi
No Relationships to Disclose
 
Jiongliang Wang
No Relationships to Disclose
 
Jie Xu
No Relationships to Disclose
 
Jibin Li
No Relationships to Disclose
 
Suixing Zhong
No Relationships to Disclose
 
Xiongying Jiang
No Relationships to Disclose
 
Qi-Feng Chen
No Relationships to Disclose
 
Yue Hu
No Relationships to Disclose
 
Song Chen
No Relationships to Disclose
 
Xintong Wu
No Relationships to Disclose
 
YiMin Zhang
No Relationships to Disclose
 
Yujia Song
No Relationships to Disclose
 
Genjun Tan
No Relationships to Disclose
 
Yunan Zhang
No Relationships to Disclose